Which predicts the cardiovascular risk best in elderly metabolic syndrome patients: ATP III or IDF?


AYDIN S., Gemalmaz A., Nayir T., Ozkan S.

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.41, no.1, pp.125-129, 2011 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 41 Issue: 1
  • Publication Date: 2011
  • Doi Number: 10.3906/sag-0912-496
  • Title of Journal : TURKISH JOURNAL OF MEDICAL SCIENCES
  • Page Numbers: pp.125-129

Abstract

Aim: As metabolic syndrome (MetS) is one of the major determinants of cardiovascular disease, it is important to detect and intervene with MetS in order to minimize cardiovascular risk. The objectives of this study were to identify the prevalence of MetS in our elderly patients and to evaluate the ability IDF and ATP III to predict the cardiovascular risk.